Status:
COMPLETED
Nutritional Intervention to Improve Sleep Quality and Improve Next-day Mood and Cognitive Benefits
Lead Sponsor:
Société des Produits Nestlé (SPN)
Conditions:
Sleep
Eligibility:
All Genders
25-50 years
Phase:
NA
Brief Summary
The study aim to test the effect of a meal complement to be taken in combination with an evening meal with a glycemic load of 55, to improve sleep quality.
Detailed Description
Considering emerging evidence on the role of the macro and micro-nutrient composition of evening meals, the intervention used in this study will be designed to provide the necessary nutrients to promo...
Eligibility Criteria
Inclusion
- Willing and able provide written informed consent (in English)
- Aged 25-50
- BMI range from 18.5 to 24.9 kg/m2
- Subjective sleep complaints (PSQI \> 5)
Exclusion
- Diagnosed food allergy or other intolerance to the investigational products, control products and standardized meals
- Significant past medical and psychiatric history and ongoing chronic conditions for example cardiovascular disease, respiratory disease, metabolic disorder, endocrine disorder (e.g. diabetes mellitus, history of hypoglycemia), and neurological and psychiatric conditions, and conditions that the investigator deem inappropriate to enter the clinical trials
- Significant medication history including use of corticosteroid in oral or systemic format and antidepressants (e.g. Selective Serotonin Reuptake Inhibitors, Monoamine Oxidase Inhibitors)
- Pregnant or intending to conceive during the course of clinical trial and up to one month after trial conclusion, or not able to comply with a highly effective form of birth control or lactating during the clinical trial. Highly effective contraception includes hormonal methods, such as the contraceptive pill or implant, or an intrauterine device (IUD), or barrier methods such as diaphragm plus spermicide or condom plus spermicide. Pregnancy status will be assessed using urinary dipsticks at the beginning and end of the study period (V0 and V9).
- Parents of children less than 12 months of age, which is a known factor of sleep disturbances.
- Peri- and post-menopausal women
- Known or diagnosed sleep disorders
- Special diets, including for instance halal food preference, vegetarian, high protein or weight loss program, and diets with either too low (\< 35% daily energy from CHO; e.g., ketogenic diet, Atkins diet, zero-carb diet, low-carb paleo/Mediterranean diet, carb cycling diet) or too high carbohydrate (\>70% daily energy from CHO) content .
- Chronic exercisers, defined as subjects exercising \> 1 h/day for at least 5 days/week
- Caffeine consumption over the recommended daily limit (above 400 mg; equivalent to approximately 4-5 cups of coffee)
- Substance abuse including over the limit alcohol consumption (2 standard drinks/day for males, 1 standard drink/day for female)
- Cigarette and Tobacco Smokers
- Intake of dietary supplements that may affect sleep conditions (e.g. melatonin, theanine, tryptophan, GABA, magnesium, zinc)
- Subjects not willing and/or not able to comply with scheduled visits and the requirements of the study protocol.
- Participating in other clinical trials or had been participating in other clinical trial in the preceding 1 month.
- Subjects belonging to a household where at least one other person is taking part in the trial.
Key Trial Info
Start Date :
March 23 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 12 2022
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT05372900
Start Date
March 23 2022
End Date
December 12 2022
Last Update
July 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre for Sleep and Cognition, NUS Yong Loo Lin School of Medicine
Singapore, Singapore, 117549